Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_single_gel_8d.class.cls #double_gel_8d_versus_single_gel_8d_repos |
Phenotype | class.cls#double_gel_8d_versus_single_gel_8d_repos |
Upregulated in class | double_gel_8d |
GeneSet | GERY_CEBP_TARGETS |
Enrichment Score (ES) | 0.4399271 |
Normalized Enrichment Score (NES) | 1.5745685 |
Nominal p-value | 0.008988764 |
FDR q-value | 0.080765426 |
FWER p-Value | 1.0 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | RGS16 | RGS16 Entrez,  Source | regulator of G-protein signalling 16 | 42 | 0.784 | 0.0382 | Yes |
2 | TNFAIP6 | TNFAIP6 Entrez,  Source | tumor necrosis factor, alpha-induced protein 6 | 64 | 0.710 | 0.0741 | Yes |
3 | ELOVL6 | ELOVL6 Entrez,  Source | ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast) | 120 | 0.589 | 0.1011 | Yes |
4 | LSS | LSS Entrez,  Source | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 126 | 0.572 | 0.1310 | Yes |
5 | GCH1 | GCH1 Entrez,  Source | GTP cyclohydrolase 1 (dopa-responsive dystonia) | 192 | 0.482 | 0.1515 | Yes |
6 | DBP | DBP Entrez,  Source | D site of albumin promoter (albumin D-box) binding protein | 195 | 0.480 | 0.1767 | Yes |
7 | LPL | LPL Entrez,  Source | lipoprotein lipase | 230 | 0.451 | 0.1980 | Yes |
8 | ECHS1 | ECHS1 Entrez,  Source | enoyl Coenzyme A hydratase, short chain, 1, mitochondrial | 260 | 0.427 | 0.2184 | Yes |
9 | BCKDHB | BCKDHB Entrez,  Source | branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease) | 271 | 0.419 | 0.2398 | Yes |
10 | FOS | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 299 | 0.398 | 0.2588 | Yes |
11 | CXCL1 | CXCL1 Entrez,  Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 309 | 0.392 | 0.2788 | Yes |
12 | TRIB3 | TRIB3 Entrez,  Source | tribbles homolog 3 (Drosophila) | 317 | 0.384 | 0.2985 | Yes |
13 | MVD | MVD Entrez,  Source | mevalonate (diphospho) decarboxylase | 328 | 0.380 | 0.3178 | Yes |
14 | ACSL1 | ACSL1 Entrez,  Source | acyl-CoA synthetase long-chain family member 1 | 335 | 0.375 | 0.3372 | Yes |
15 | HMGCR | HMGCR Entrez,  Source | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 434 | 0.327 | 0.3471 | Yes |
16 | JUNB | JUNB Entrez,  Source | jun B proto-oncogene | 470 | 0.312 | 0.3609 | Yes |
17 | SH3GL3 | SH3GL3 Entrez,  Source | SH3-domain GRB2-like 3 | 574 | 0.276 | 0.3677 | Yes |
18 | IER2 | IER2 Entrez,  Source | immediate early response 2 | 634 | 0.257 | 0.3769 | Yes |
19 | C3 | C3 Entrez,  Source | complement component 3 | 636 | 0.257 | 0.3904 | Yes |
20 | BTG2 | BTG2 Entrez,  Source | BTG family, member 2 | 724 | 0.234 | 0.3961 | Yes |
21 | NSDHL | NSDHL Entrez,  Source | NAD(P) dependent steroid dehydrogenase-like | 829 | 0.216 | 0.3997 | Yes |
22 | MAFK | MAFK Entrez,  Source | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 832 | 0.216 | 0.4110 | Yes |
23 | IFRD1 | IFRD1 Entrez,  Source | interferon-related developmental regulator 1 | 837 | 0.215 | 0.4221 | Yes |
24 | IGF2 | IGF2 Entrez,  Source | insulin-like growth factor 2 (somatomedin A) | 867 | 0.212 | 0.4311 | Yes |
25 | XDH | XDH Entrez,  Source | xanthine dehydrogenase | 896 | 0.208 | 0.4399 | Yes |
26 | DNAJB9 | DNAJB9 Entrez,  Source | DnaJ (Hsp40) homolog, subfamily B, member 9 | 1133 | 0.178 | 0.4316 | No |
27 | FOXG1 | 1387 | 0.158 | 0.4208 | No | ||
28 | ATF3 | ATF3 Entrez,  Source | activating transcription factor 3 | 1414 | 0.156 | 0.4271 | No |
29 | HP | HP Entrez,  Source | haptoglobin | 1480 | 0.151 | 0.4301 | No |
30 | PROCR | PROCR Entrez,  Source | protein C receptor, endothelial (EPCR) | 1750 | 0.134 | 0.4169 | No |
31 | LCN2 | LCN2 Entrez,  Source | lipocalin 2 (oncogene 24p3) | 1885 | 0.127 | 0.4135 | No |
32 | RDH11 | RDH11 Entrez,  Source | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 2018 | 0.121 | 0.4100 | No |
33 | S100A3 | S100A3 Entrez,  Source | S100 calcium binding protein A3 | 2080 | 0.118 | 0.4116 | No |
34 | CD1D1 | 2101 | 0.118 | 0.4163 | No | ||
35 | PPARG | PPARG Entrez,  Source | peroxisome proliferative activated receptor, gamma | 2538 | 0.101 | 0.3888 | No |
36 | MKNK2 | MKNK2 Entrez,  Source | MAP kinase interacting serine/threonine kinase 2 | 2879 | 0.089 | 0.3678 | No |
37 | DUSP1 | DUSP1 Entrez,  Source | dual specificity phosphatase 1 | 3275 | 0.077 | 0.3421 | No |
38 | ORM1 | ORM1 Entrez,  Source | orosomucoid 1 | 3328 | 0.075 | 0.3421 | No |
39 | EREG | EREG Entrez,  Source | epiregulin | 3625 | 0.068 | 0.3234 | No |
40 | MYD116 | 3865 | 0.063 | 0.3087 | No | ||
41 | ALDH3A1 | ALDH3A1 Entrez,  Source | aldehyde dehydrogenase 3 family, memberA1 | 4305 | 0.053 | 0.2784 | No |
42 | SERPINI1 | SERPINI1 Entrez,  Source | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | 4533 | 0.048 | 0.2638 | No |
43 | ABCD2 | ABCD2 Entrez,  Source | ATP-binding cassette, sub-family D (ALD), member 2 | 4613 | 0.046 | 0.2602 | No |
44 | NR2F6 | NR2F6 Entrez,  Source | nuclear receptor subfamily 2, group F, member 6 | 5110 | 0.036 | 0.2247 | No |
45 | ZFAND2A | ZFAND2A Entrez,  Source | zinc finger, AN1-type domain 2A | 5335 | 0.031 | 0.2095 | No |
46 | ANGPTL4 | ANGPTL4 Entrez,  Source | angiopoietin-like 4 | 5417 | 0.030 | 0.2049 | No |
47 | HGF | HGF Entrez,  Source | hepatocyte growth factor (hepapoietin A; scatter factor) | 5893 | 0.020 | 0.1702 | No |
48 | FGF7 | FGF7 Entrez,  Source | fibroblast growth factor 7 (keratinocyte growth factor) | 5913 | 0.020 | 0.1698 | No |
49 | NR1D1 | NR1D1 Entrez,  Source | nuclear receptor subfamily 1, group D, member 1 | 6399 | 0.010 | 0.1337 | No |
50 | KLF4 | KLF4 Entrez,  Source | Kruppel-like factor 4 (gut) | 7004 | -0.002 | 0.0883 | No |
51 | DCN | DCN Entrez,  Source | decorin | 8220 | -0.028 | -0.0018 | No |
52 | PER2 | PER2 Entrez,  Source | period homolog 2 (Drosophila) | 8421 | -0.033 | -0.0152 | No |
53 | PLAUR | PLAUR Entrez,  Source | plasminogen activator, urokinase receptor | 8677 | -0.038 | -0.0324 | No |
54 | PIM1 | PIM1 Entrez,  Source | pim-1 oncogene | 9075 | -0.048 | -0.0598 | No |
55 | SERPINB2 | SERPINB2 Entrez,  Source | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 9455 | -0.058 | -0.0853 | No |
56 | RASL11B | RASL11B Entrez,  Source | RAS-like, family 11, member B | 9784 | -0.067 | -0.1065 | No |
57 | APBB1IP | APBB1IP Entrez,  Source | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 9957 | -0.073 | -0.1156 | No |
58 | GADD45G | GADD45G Entrez,  Source | growth arrest and DNA-damage-inducible, gamma | 10034 | -0.076 | -0.1173 | No |
59 | RRAD | RRAD Entrez,  Source | Ras-related associated with diabetes | 10198 | -0.081 | -0.1253 | No |
60 | S100A8 | S100A8 Entrez,  Source | S100 calcium binding protein A8 | 10280 | -0.084 | -0.1270 | No |
61 | CRABP2 | CRABP2 Entrez,  Source | cellular retinoic acid binding protein 2 | 10545 | -0.093 | -0.1420 | No |
62 | RNH1 | RNH1 Entrez,  Source | ribonuclease/angiogenin inhibitor 1 | 11349 | -0.129 | -0.1958 | No |
63 | HMOX1 | HMOX1 Entrez,  Source | heme oxygenase (decycling) 1 | 11363 | -0.129 | -0.1899 | No |
64 | CSPG2 | CSPG2 Entrez,  Source | chondroitin sulfate proteoglycan 2 (versican) | 11420 | -0.132 | -0.1872 | No |
65 | CD47 | CD47 Entrez,  Source | CD47 molecule | 11473 | -0.136 | -0.1839 | No |
66 | BAIAP2 | BAIAP2 Entrez,  Source | BAI1-associated protein 2 | 11565 | -0.141 | -0.1833 | No |
67 | CLU | CLU Entrez,  Source | clusterin | 11779 | -0.155 | -0.1912 | No |
68 | GADD45B | GADD45B Entrez,  Source | growth arrest and DNA-damage-inducible, beta | 11783 | -0.155 | -0.1832 | No |
69 | ACTA2 | ACTA2 Entrez,  Source | actin, alpha 2, smooth muscle, aorta | 12216 | -0.193 | -0.2056 | No |
70 | DDIT3 | DDIT3 Entrez,  Source | DNA-damage-inducible transcript 3 | 12335 | -0.209 | -0.2035 | No |
71 | PRNP | PRNP Entrez,  Source | prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) | 12376 | -0.212 | -0.1953 | No |
72 | ID2 | ID2 Entrez,  Source | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 12405 | -0.215 | -0.1860 | No |
73 | BAG3 | BAG3 Entrez,  Source | BCL2-associated athanogene 3 | 12420 | -0.218 | -0.1756 | No |
74 | NRP1 | NRP1 Entrez,  Source | neuropilin 1 | 12499 | -0.229 | -0.1694 | No |
75 | ABCA1 | ABCA1 Entrez,  Source | ATP-binding cassette, sub-family A (ABC1), member 1 | 12519 | -0.231 | -0.1586 | No |
76 | CD68 | CD68 Entrez,  Source | CD68 molecule | 12654 | -0.254 | -0.1553 | No |
77 | HBEGF | HBEGF Entrez,  Source | heparin-binding EGF-like growth factor | 12714 | -0.267 | -0.1456 | No |
78 | CRYAB | CRYAB Entrez,  Source | crystallin, alpha B | 12728 | -0.271 | -0.1323 | No |
79 | PEA15 | PEA15 Entrez,  Source | phosphoprotein enriched in astrocytes 15 | 12899 | -0.321 | -0.1282 | No |
80 | PLAT | PLAT Entrez,  Source | plasminogen activator, tissue | 13010 | -0.371 | -0.1169 | No |
81 | ID3 | ID3 Entrez,  Source | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 13077 | -0.411 | -0.1002 | No |
82 | FHL2 | FHL2 Entrez,  Source | four and a half LIM domains 2 | 13196 | -0.560 | -0.0795 | No |
83 | CXCL5 | CXCL5 Entrez,  Source | chemokine (C-X-C motif) ligand 5 | 13257 | -0.714 | -0.0463 | No |
84 | RGS2 | RGS2 Entrez,  Source | regulator of G-protein signalling 2, 24kDa | 13309 | -0.997 | 0.0025 | No |